Owens & Minor executive pay dropped ahead of realignment

Owens & Minor executive pay dropped year-over-year, the device manufacturer told investors ahead of this week’s annual meeting.

Richmond, Virginia-based Owens & Minor (NYSE:OMI) is the 13th-largest medical device company in the world, according to Medical Design & Outsourcing‘s 2022 Medtech Big 100 list. That ranking was based on Owens & Minor’s $9.8 billion in 2021 revenue.

The company reported nearly $10.0 billion in revenue for 2022 and acquired home medical equipment developer Apria for $1.7 billion last year.

Net income soared from $30 million in 2020 to $222 million in 2021 thanks in part to COVID-19 pandemic sales of personal protective equipment, but decreased to $22 million last year. The company announced a realignment initiative in February and cut employees in March.

“We believe this program will enhance our strong quality of service to our customers, increase our margins, and allow us to…

Read more
  • 0

Owens & Minor completes $1.6B acquisition of Apria

Owens & Minor (NYSE:OMI) announced today that it closed its previously announced $1.6 billion acquisition of Apria.

The Richmond, Virginia-based company previously announced the planned acquisition of Apria, a developer of home medical equipment for respiratory therapy, sleep apnea treatment, negative pressure wound therapy, and continuous glucose monitoring, in January 2022.

According to a news release, the company funded the purchase with a combination of debt and cash on hand. Earlier this month, the company launched a private offering worth $500 million in senior notes with the intention of using the proceeds to finance the Apria acquisition.

“We are excited to finalize the acquisition and for Apria to become part of Owens & Minor,” President and CEO Edward A. Pesicka said in the release. “Apria is a perfect complement to our Byram business. This portfolio expansion strengthens Owens & Minor’s position in the fast-growing home health indu…

Read more
  • 0